United States:
Trends In Inter Partes Review Of Life Sciences Patents
To print this article, all you need is to be registered or login on Mondaq.com.
A statistical analysis of inter partes review proceedings before
the Patent Trial and Appeal Board shows that the PTAB is not a
''death squad'' for patents.
Click here to read the full text of this article.
Originally published by Bloomberg BNA
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
"Patent Marking Regarding Software Medical Devices"
Marshall, Gerstein & Borun LLP
The IPO Law Journal recently published a paper titled "Patent Marking Regarding Software Medical Devices." The paper discusses an overview of patent marking-related case law...